Percheron Therapeutics LimitedASX: PER

Listing Rule waiver to allow quotation of PERAQ options

· Issued by Percheron Therapeutics Limited via ASX

Filed with ASX · · 2 pages · English

Summary by 6ix AI

Percheron Therapeutics Limited has received a waiver from ASX to allow the quotation of certain options under the security code PERAQ. The options include those issued during a recent capital raising and are intended to be consolidated into a single class of quoted securities. The company plans to lodge a prospectus to facilitate secondary trading of shares upon exercise of these options. An indicative timetable for the proposed quotation of the options has been provided.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Release

ASX Announcement Listing Rule waiver to allow quotation of PERAQ options Melbourne, Australia - 30 October 2026: Percheron Therapeutics Limited (ASX: PER) (Company) advises that on 29 October 2026, ASX granted the Company a waiver from Listing Rule 6.23.4, to enable the Company to apply for...

Percheron Therapeutics Limited on 6ix

Earlier from Percheron Therapeutics

Later from Percheron Therapeutics

All Percheron Therapeutics news releases